Molecular mechanisms of cardiomyocyte dedifferentiation via TCF3
Description: Heart failure caused by myocardial infarction (MI) and cardiomyocyte death is a global public health problem. Most current therapies focus on preventing adverse ventricular remodelling after MI, but do not compensate for the loss of cardiomyocytes. Studies have shown that adult zebrafish and neonatal mouse hearts regenerate after MI, a process in which cardiomyocyte dedifferentiation prior to proliferation is essential. Although cardiomyocyte proliferation has been extensively studied, much less is known about dedifferentiation. There is currently no therapeutic approach to human heart regeneration. Therefore, further understanding of cardiomyocyte dedifferentiation/proliferation and identification of novel targets for cardiac regeneration is very important. Recently, we found that the transcription factor TCF3 induces cardiomyocyte dedifferentiation. My preliminary data suggest that TCF3 also stimulates cardiomyocyte proliferation in vitro and in vivo. The central aim of this proposal is to elucidate the mechanisms regulating cardiomyocyte dedifferentiation and proliferation in order to identify a novel therapeutic target for cardiac regeneration. Using both an animal model and a human heart slice model, this project will significantly increase our understanding of the mechanisms involved in cardiomyocyte proliferation, which can be exploited therapeutically for cardiac regeneration.
Funder: British Heart Foundation
Amount: £298,200
Funding type: research
Funder scheme: Project Grant
Start date: 2025-01-06
End date: 2028-01-05
Investigator: Ryuichi Fukuda (lead)
Institution: King's College London
Subfield: Molecular Biology
Domain: Life Sciences
Funded outputs count: 0
Funder award ID: PG/24/11405
OpenAlex ID: G2275614780
